These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17631152)
1. Irritable bowel syndrome: shifting the focus toward the gut microbiota. Shanahan F Gastroenterology; 2007 Jul; 133(1):340-2. PubMed ID: 17631152 [No Abstract] [Full Text] [Related]
2. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Parkes GC; Brostoff J; Whelan K; Sanderson JD Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268 [TBL] [Abstract][Full Text] [Related]
3. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270 [TBL] [Abstract][Full Text] [Related]
5. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Kajander K; Krogius-Kurikka L; Rinttilä T; Karjalainen H; Palva A; Korpela R Aliment Pharmacol Ther; 2007 Aug; 26(3):463-73. PubMed ID: 17635381 [TBL] [Abstract][Full Text] [Related]
6. [Clinico-physiological rationale for the use of the mesodiencephalic modulation in combination with synobiotics in the irritable bowel syndrome]. Efendieva MT; Gusakova EV Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (2):25-8. PubMed ID: 18507185 [No Abstract] [Full Text] [Related]
7. [Bowel dysfunctional microflora: clinical significance and prospects for its therapy]. Zviagintseva TD; Sergienko EI Eksp Klin Gastroenterol; 2003; (3):70-4, 118. PubMed ID: 14556552 [TBL] [Abstract][Full Text] [Related]
8. [Intestinal microbiota in digestive disorders. Probiotics, prebiotics and symbiotics]. Valdovinos-Díaz MÁ Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():25-7. PubMed ID: 24041049 [No Abstract] [Full Text] [Related]
10. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517 [TBL] [Abstract][Full Text] [Related]
11. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. O'Mahony SM; Marchesi JR; Scully P; Codling C; Ceolho AM; Quigley EM; Cryan JF; Dinan TG Biol Psychiatry; 2009 Feb; 65(3):263-7. PubMed ID: 18723164 [TBL] [Abstract][Full Text] [Related]
12. [Hepon, promoter of local immunity in the complex therapy of dysfunctional microflora in bowel disorders]. Parfenov AI; Ruchkina IN Eksp Klin Gastroenterol; 2003; (3):66-9, 118. PubMed ID: 14556551 [TBL] [Abstract][Full Text] [Related]
13. Alterations in intestinal microbial flora and human disease. Othman M; Agüero R; Lin HC Curr Opin Gastroenterol; 2008 Jan; 24(1):11-6. PubMed ID: 18043226 [TBL] [Abstract][Full Text] [Related]
14. Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case control study. Rana SV; Sinha SK; Sikander A; Bhasin DK; Singh K Trop Gastroenterol; 2008; 29(1):23-5. PubMed ID: 18564663 [TBL] [Abstract][Full Text] [Related]